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Summary: The estimated heritability of human body mass index (BMI) is close to 75%, 
but identified genetic variants explain only a small fraction of interindividual body-
weight variation. Inherited epigenetic variants identified in mouse models named 
“metastable epialleles” could in principle explain this “missing heritability”. We 
provide evidence that methylation in a variably methylated region (VMR) in the pro-
opiomelanocortin gene (POMC) - particularly in postmortem human laser-
microdissected MSH (melanocyte-stimulating-hormone) positive neurons - is strongly 
associated with individual BMI. Using cohorts from different ethnic backgrounds, 
including a Gambian cohort, we found evidence suggesting that methylation of the 
POMC VMR is established in the early embryo and that offspring methylation 
correlates with the paternal somatic methylation pattern. Furthermore it is associated 
with levels of maternal one-carbon metabolites at conception and stable during 
postnatal life. Together these data suggest that the POMC VMR may be a human 
metastable epiallele that influences body weight regulation.  
 
Introduction: 
Family and twin studies indicate that adiposity - assessed as body mass index (BMI) - is 
highly heritable. A recent meta-analysis estimated BMI heritability up to 75% in twins and 
46% in families (Elks et al. 2012). However, despite enormous efforts (Speliotes et al., 2010) 
including whole genome sequencing (Yang et al., 2015), the genetic variants identified thus 
far together explain less than 30% of individual BMI and body weight variation (Locke et al., 
2015). The last few years have seen efforts to explain this “missing heritability” by exploring 
the relation between epigenetic modifications and body weight regulation (Eichler et al., 
2010). However, the molecular nature and ontogeny have remained elusive (Waterland, 
2014). The most comprehensive search for obesity-related DNA methylation changes in 
humans based on the Illumina 450K-array recently revealed HIF3A methylation variants 
associated with BMI (Dick et al., 2014; Murphy and Mill, 2014). However as these were 
linked with single nucleotide polymorphisms (SNPs) in cis, they may represent secondary 
epigenetic differences that are driven by genetic variation.  
The most compelling data supporting epigenetic regulation of body weight/BMI is derived 
from mouse models identifying changes in DNA methylation and gene expression (Dalgaard 
et al., 2016; Radford et al., 2014). For example cloned (Tamashiro et al., 2002) and isogenic 
inbred (Koza et al., 2006) mouse strains are divergent in their body weight early in life 
despite sharing the same genomes and environment.  
At the molecular level these inherited, stable epigenetic variants were initially shown for fur 
color and body weight in the agouti viable yellow (Avy) mouse (Morgan et al., 1999). In the Avy 
mutant strain epigenetic variants are triggered by a transposable element (intracisternal A 
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particle, IAP). Hypermethylation of this retrotransposon in the early embryo leads to stable, 
non-tissue specific epigenetic variation among isogenic Avy mice that influences fur color and 
metabolic phenotypes. Accordingly, Avy was dubbed a “metastable epiallele” (ME) (Rakyan et 
al., 2002). This concept of a retro-element triggered ME was confirmed in the murine AxinFu 
mutation, at which interindividual variation in methylation is associated with tail kinking 
(Rakyan et al., 2002). It was shown that methylation at MEs occurs stochastically but can in 
part be modified by maternal intake of nutrients related to one-carbon metabolism (Waterland 
et al., 2006; Waterland and Jirtle, 2003). In addition the methylation state can in part be 
transmitted via a parental germline, either maternal (Avy) (Morgan et al., 1999) or paternal 
(AxinFu) (Rakyan et al., 2003). Thus, epigenetic differences at metastable epialleles represent 
a potential molecular mechanism to explain stable inheritance that is not linked to genetic 
variants.  
 
Here we pursued a candidate gene approach to identify BMI-associated DNA methylation 
differences. We focused our search on the POMC gene because individuals homozygous for 
variants in the coding region of POMC - giving rise to the MSH-peptides that mediate the 
anorectic functions of leptin - develop early onset severe obesity (Krude et al., 1998). Since 
heterozygous carriers are obese to a lesser extent (Farooqi et al., 2006; Krude et al., 2003), 
POMC represents a good candidate for investigating the potential effects of methylation 
differences on gene expression and obesity/BMI.  
 
We previously identified a POMC variably-methylated region (VMR) located at the intron2-
exon3 border (Figure 1A), which is more frequently hypermethylated in peripheral blood cells 
(PBCs) of obese children (Kuehnen et al., 2012). Hypermethylation of the VMR seems to be 
triggered by adjacent Alu elements in intron2 (Figure 1A) since the homologous CpGs in 
species without those Alu elements (mouse and lemur) are not methylated. We have shown 
that hypermethylation in this VMR decreases P300 enhancer binding and POMC 
transcription and is present before the onset of obesity (Kuehnen et al., 2012) suggesting a 
functional effect of the methylation variant on POMC gene expression. Here we extend our 
previous study to look at POMC methylation in PBCs and MSH neurons in adults. 
 
Results  
 
POMC hypermethylation in obese adults in peripheral blood cells and MSH neurons 
Initially, we performed bisulfite-pyrosequencing at each of 9 POMC-VMR-CpG-sites to 
reproduce our previous finding of hypermethylation in obese compared to normal weight 
children (Kuehnen et al., 2012). As in the previous study we found a significant positive 
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correlation of methylation across CpG sites -2 to +5 with individual BMI-standard deviation 
score (SDS) (Supplemental Figure S1). Thereafter we analyzed this region in obese versus 
normal weight adult individuals. We again found variable methylation at the border of intron2-
exon3 and significant hypermethylation at positions +1, +2, +3 and +5 (Figure 1 B). Moreover 
we found a significant positive correlation of average methylation across CpG sites -2 to +5 
with BMI (r=0.18, p=0.006) (Figure 1 C). 
 
We next performed laser-microdissection of MSH-positive arcuate nucleus neurons from 
postmortem human brain. POMC gene expression in those neurons is most crucial for 
individual body weight regulation. Laser-microdissected MSH-positive neurons were 
collected from 41 obese and normal weight individuals (Supplemental Figure S1) and the 
methylation status was analyzed by bisulfite pyrosequencing  (see Experimental 
Procedures). Again we observed variable methylation at the intron2-exon3 border, and 
POMC methylation across sites -2 to +5 of the MSH neurons was positively correlated with 
individual BMI (r=0.34, p=0.025) (Figure 1D). Together with our previous finding that 
hypermethylation at positions -2 to +5 decreases POMC gene expression (Kuehnen et al., 
2012), it is likely that hypermethylation of the POMC gene in MSH neurons from obese 
individuals results in a lower expression of POMC gene product, which might inhibit normal 
satiety responses and promote obesity. This correlation would imply that a 10% increase in 
methylation is associated with 2.8 kg/m2 increase in BMI (p=0.025) (Figure 1D), a much 
stronger effect than observed for top GWAS SNPs associated with obesity, such as at FTO 
(0.39 kg/m2 per allele) (Loos, 2012; Murphy and Mill, 2014). 
 
Non-tissue specificity of POMC methylation 
We analyzed the extent of systemic (cross-tissue) variation in POMC methylation. A 
comparison of POMC methylation of neurons within the arcuate nucleus with methylation in 
PBCs in a subset of 14 postmortem studied individuals revealed a strong positive correlation 
(r=0.63, p=0.014) (Figure 2A) suggesting, that cells from different germ layers - ectoderm 
(brain) and mesoderm (PBC) - maintain a similar methylation level. We further confirmed this 
by analyzing an independent second set of tissue-samples from different individuals (see 
Experimental Procedures). Again we found high intra-individual correlation of methylation in 
ectoderm (brain) and mesoderm (kidney) samples (r=0.7, p=0.002) (Figure 2B). These data 
argue that methylation across the POMC VMR may be established very early during 
development, before separation of germ layers at gastrulation.  
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Longitudinal stability of POMC methylation  
To further test the longitudinal stability of interindividual variation in POMC methylation we 
analyzed the methylation in DNA extracted from newborn screening cards – a blood 
collection which is routinely performed after birth between day 3 and 10 postpartum – and 
compared this with the POMC methylation status of the same individual in a second blood 
collection performed later in life (n=52; mean time span: 11.69 years; range: 3-24 years). We 
observed a strong correlation of methylation within individuals across this time period (Figure 
2 C) indicating that the POMC methylation pattern is stable over time and not strongly 
influenced by postnatal environment.  
 
Impact of genetic variation in cis on POMC methylation 
Several epigenome-wide association studies (EWAS) have identified methylation variants 
(meQTL) associated with SNPs in cis (Dick et al., 2014), implying that they may simply 
represent secondary epigenetic differences resulting from genetic variation (Murphy and Mill, 
2014). We searched for meQTL at POMC by sequencing the entire region of the POMC 
gene including the promoter and 3’UTR’ in two cohorts of normal weight children of different 
genetic -European and West African- origin (see Experimental Procedures). None of the 
genetic variants present, including rs713586 - the only known BMI-associated POMC SNP 
identified in a GWAS meta-analysis (Speliotes et al., 2010) - was associated with methylation 
across the 9 VMR-CpGs (Supplemental Figure S2 A, B). In addition, although the African 
and European cohorts show significant differences in their SNP characteristics 
(Supplemental Figure S2 A, B) average POMC methylation in both cohorts was essentially 
identical (Supplemental Figure S2 C). It is therefore unlikely that the POMC methylation 
variant is driven by a genetic polymorphism. 
 
Paternal impact on POMC methylation 
 
To further analyze a potential genetic effect on the POMC methylation variant, we 
investigated the inheritance of methylation status at the POMC VMR in 47 family trios of 
obese children and their parents. Notably, methylation of a child’s POMC VMR correlated 
only with its father’s POMC methylation level (Figure 3A), and not with that of its mother 
(Figure 3B). These data suggest a partial transmission of the POMC VMR methylation state 
through the paternal germline that is not driven by genetic variation. To investigate the 
underlying mechanism explaining this correlation between paternal and offspring 
methylation, we analyzed POMC methylation in sperm and blood (PBC) DNA of 17 German 
men. Interestingly, POMC VMR methylation in sperm was significantly lower than that in 
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blood (Supplemental Figure S3 A), consistent with a loss of methylation during germ line 
differentiation as has been shown for imprinted regions (Monk, 2015). PBC methylation is 
however correlated with BMI in the same individuals (r=0.54, p=0.025) (Supplemental Figure 
S3 B). These data suggest that paternal transmission of the epigenetic state at the POMC 
VMR occurs by some mechanism other than DNA methylation.  
 
POMC methylation is not influenced by maternal body weight changes during pregnancy 
To further search for the origin of POMC VMR methylation we assessed the potential 
influence of the early in utero environment. We analyzed 33 European mother-child pairs and 
tested for a correlation of maternal body weight during pregnancy with the child's POMC 
methylation level. Neither maternal body weight at conception nor the weight change during 
pregnancy was correlated with POMC methylation level determined in the child's PBC-DNA 
(Supplemental Figure S3).  
 
POMC methylation is influenced by one-carbon (C1) metabolism 
Establishment of DNA methylation at human MEs has shown to be sensitive to C1-
metabolites at the time of conception. One-carbon metabolism is central because it regulates 
the supply of methyl groups required for DNA methylation. Betaine and 5-
methyltetrahydrofolate are methyl donors for the methylation of methionine, converting it to 
S-adenosylmethionine (SAM). In transmethylation reactions, SAM donates a methyl group 
and is transformed into S-adenosylhomocysteine (SAH), which is then metabolized into 
homocysteine. To analyze the impact of these C1-metabolites on POMC methylation we 
investigated a West African cohort of 144 mother-child pairs from a rural area of The 
Gambia, in which data on maternal periconceptional C1-metabolites were available 
(Dominguez-Salas et al., 2014). In this region the alternation of rainy and dry seasons leads 
to large changes in the environment affecting maternal nutrition and the supply of C1-
metabolites (Dominguez-Salas et al., 2013). We found lower DNA methylation at the POMC 
VMR in children conceived in the dry season compared to those conceived in the rainy 
season (Table 1A), consistent with previous observations at known MEs (Dominguez-Salas 
et al., 2014; Silver et al., 2015). Testing for a direct influence of maternal serum C1-
metabolites, a robust and significant negative correlation for S-adenosylhomocysteine (SAH) 
and positive correlations with betaine and the ratio of S-adenosylmethionine (SAM) to S-
adenosylhomocysteine (SAM:SAH) were found at all CpGs -2 to +7 (Table 1A, B and 
Experimental Procedures).  
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Discussion 
Our findings in different obese cohorts and postmortem studies indicate that methylation of 
the human POMC VMR is correlated with individual body weight. The finding of reduced 
POMC gene expression in the presence of the hypermethylated variant (Kuehnen et al., 
2012) together with our observation that the same association is observed in MSH-positive 
arcuate nucleus neurons suggest that hypermethylation at the POMC VMR may be 
functionally related to an individual’s body weight.  
In addition the findings in the present study imply that the POMC VMR shares a set of 
common characteristics with the mouse Avy locus. Namely, it is i) triggered by a transposable 
element; ii) sensitive to nutritional modification by C1-metabolites during early embryonic 
development; iii) in part transmitted via one parental germline; iv) stable over the life course; 
and v) positively correlated with body weight. In addition, our data argue against an influence 
of maternal body weight during pregnancy and of genetic variation at the POMC gene locus. 
In this respect the observed POMC VMR methylation differs fundamentally from other 
identified methylation variants that are associated with obesity, which result either from non-
inherited environmental influences or represent secondary epigenetic differences resulting 
primarily from genetic variation (Murphy and Mill, 2014).  
 
Together, these complementary data across multiple populations argue that the variation of 
the POMC VMR resembles a metastable epiallele, like those described in the mouse Avy 
locus. As already shown for the Avy locus, methylation of the POMC VMR appears to be 
established before the separation of the germ-layers during the very early stages of genome 
re-methylation, resulting in significant correlation of methylation levels across somatic cell 
types derived from different germ layers. We cannot however exclude completely the 
possibility that an environmental exposure in adulthood may influence methylation patterns in 
multiple tissues. Additionally, early-embryonic establishment of POMC VMR methylation 
appears to be influenced by the availability of C1-metabolites in the maternal circulation 
around the time of conception.  Our data also point to the influence of some other factor 
transmitted from the father to the offspring, although the mechanism is unknown. One 
possibility is the transmission of sperm micro-RNAs (Gapp et al., 2014; Wagner et al., 2008). 
Our interpretation of these various observations is that POMC methylation is determined 
combinatorially by stochastic epigenetic events during early embryonic development (which 
are influenced by maternal nutrition) and by non-genetic paternal transmission, although 
further studies in independent samples will be required to confirm that the POMC VMR is 
acting as a metastable epiallele. 
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Importantly, our data indicating early-embryonic establishment and long-term stability of 
methylation at the POMC VMR help inform causality. In particular, together with our findings 
showing that methylation at this locus is correlated with individual BMI, these data suggest 
that individual epigenetic variation at the POMC VMR is a cause rather than a consequence 
of obesity. Moreover, if stochastic establishment of DNA methylation at the POMC VMR 
occurs before the embryo cleavage that results in monozygotic (MZ) twins, this could lead to 
a shared POMC VMR epigenotype in monozygotic twins, independent of their genetic 
identity (Waterland et al., 2010). This may offer a partial explanation for the missing 
heritability of BMI (Llewellyn et al., 2013). 
 
 
Experimental Procedures 
All procedures and measurements were approved by the Ethics Committee of the Charité 
Universitätsmedizin Berlin (EA2/131/11, EA1/019/13 and EA2/116/10), the 
Universitätsklinikum Essen (05-2954) and the joint Gambian Government/MRC Unit. The 
Gambia Ethics Committee (L2013.25) and according to the declaration of Helsinki. The 
patients and/or their parents/guardians gave informed consent. 
 
POMC genotyping analysis: 
The genomic POMC region was analyzed in DNA samples from a European cohort (Berlin, 
Charité Universitätsmedizin Berlin) and from the Gambian cohort (infants) by traditional 
Sanger sequencing on an ABI Sequencer (Applied Biosystems 3130xl, Genetic Analyzer). 
For oligo sequences and further details please see supplemental information section 
(Supplemental Table S1). 
 
DNA methylation analysis:  
DNA (500 ng) for German cohorts was extracted according to standard protocols (Promega) 
from peripheral blood cells. For Gambians, DNA was extracted from venous blood using a 
standard salting-out method (Miller et al., 1988). The samples were converted with sodium-
bisulfite (EpiTect-Kit, Qiagen). For further details of methylation analysis and DNA-extraction 
see supplemental information.  
 
Study cohorts 
 
Adult case-control cohort: The control group consists of 103 normal weight adults with a 
mean age of 48.2 ± 11.74 years and a mean BMI of 22.5 ± 1.65 kg/m2 (32 male, 71 female). 
The obese group includes 125 individuals with a mean age of 54.2 ± 8.35 years and a mean 
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BMI of 36.03 ± 5.61 kg/m2 (50 male, 75 female). The samples were part of the MesyBepo 
follow-up study (Bobbert et al., 2013). 
 
Family Trios (Essen, Germany): A total of 47 family trios each with one obese child (mean 
age 13.23 ± 2.34 years, mean BMI 30.2 ± 4.34 kg/m2) were analyzed. The fathers had a mean 
age of 44.53 ± 8.06 years and a mean BMI of 28.6 ± 5.73 kg/m2. The mothers had a mean age 
of 41.11 ± 4.11 years and a mean BMI of 28.37 ± 8.33 kg/m2. 
 
European healthy children (Berlin, Germany) (genetic variant analysis): 
84 normal weight children were analyzed with a mean BMI 18 ± 0.61 kg/m2 and a mean age of 
8.9 ± 2.01 years (female: 44, male: 40), recruited in the outpatient clinic of the Department of 
Pediatric Endocrinology, Charité Universitätsmedizin Berlin.  
 
European normal weight and obese children and mother child pairs (Berlin, Germany) (for 
POMC methylation analysis): 
76 normal weight (37 female, 39 male, average age: 5.7 ± 5.5, average BMI: 17.3 ± 3) and 
83 obese patients (43 female, 40 male, average age: 13.7 ± 1.9, average BMI: 30.83 ± 4.2) 
were recruited in the outpatient clinic of the Department of Pediatric Endocrinology of the 
Charité Universitätsmedizin Berlin. From 33 obese patients (20 female, 13 male, average 
age: 13.4, average BMI: 30.6) data were available about the body weight course of the 
mother during pregnancy. None of the mothers had gestational diabetes. 
 
Gambian mother-infant pairs (West Kiang, The Gambia): Samples originate from an 
observational prospective study (registered at http://www.clinicaltrials.gov, reference 
NCT01811641) in The Gambia, West Africa, assessing season of conception and maternal 
nutritional status on infant epigenetic outcomes (Dominguez-Salas et al., 2014; Dominguez-
Salas et al., 2013). For details see supplemental information.  
 
Human tissue samples (brain, kidney): Postmortem samples of 16 Vietnamese motor vehicle 
accident victims (Waterland et al., 2010) were collected at the human tissue bank (ILSbio, 
LLC, Chestertown, MD, USA). 
 
Longitudinal analysis of DNA methylation 
The POMC DNA methylation pattern has been analyzed longitudinally from the same 
individual (n=51; female n=24, male 27, BMI 27.92 ± 6.8 kg/m2). The first sample was 
extracted from the newborn screening card (routinely performed blood collection between 
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day 3 and 10 in Germany). The second sample originated from a blood collection at an age 
of 11.69 ± 5.5 years.  
 
 
Postmortem human brain tissue samples (Berlin):  
Hypothalamic samples of 41 individuals were obtained from autopsies performed according 
to Berlin law (Sektionsgesetz, Gesetz- und Verordnungsblatt für Berlin, 1996; 52 32, 237-
239) from the Department of Neuropathology, Charité – Universitätsmedizin Berlin. Subjects 
were selected with no history of neurodegenerative diseases or cancer (12 female, 29 male, 
average age 67 ± 12.76 years, average BMI = 32.3 ± 6.8 kg/m2).  For technical details 
especially the laser-micro dissection and immunostaining see supplemental information. 
 
Sperm-PBC sample pairs: 
Sperm- and PBC DNA pairs from the same male obese (n=7; mean age: 36.4 years; BMI: 
31.9 kg/m2) and non-obese (n=10; mean age: 36.5 years; BMI: 23.01 kg/m2) individual were 
obtained from the Center of Reproductive Medicine and Andrology, Münster, Germany (Prof. 
Gromoll). DNA was extracted as described previously (Laurentino et al., 2015). 
 
Statistical analysis: 
The DNA methylation at CpG position -2 to +7 was statistically analyzed by t-Test – either 
this 9 CpG positions in total, CpG position -2 to +5 or each CpG position separately. All the 
results were adjusted for age and sex. The linear regression between BMI and DNA 
methylation at position -2 to +5 was tested as an exploratory analysis. The DNA methylation 
mean value of CpG position -2 to +5 was analyzed against the BMI after Bonferroni 
correction for multiple testing (p=0.0005). The logistic regression was calculated with a BMI 
above 30kg/m2 as a binary outcome to obtain the risk for becoming obese. The calculations 
were performed with PASW (SPSS 21). For further details especially about the Gambian C1-
analysis see supplemental information. The error bars represent standard deviation (SD). 
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Figures and Table 
 
Figure 1:  
POMC gene structure and pyrosequencing results in an adult cohort. 
(A) The POMC gene structure indicating the location of CpG islands (green), the Alu 
elements (black boxes) and CpGs -2 to +7, which were analyzed by pyrosequencing. (B) 
Bisulfite-pyrosequencing analysis of DNA methylation in peripheral blood cells from 103 
normal weight (grey) and 125 obese (red) adult individuals. The most significant differences 
were observed at CpG position +3 and +5 (corresponding to nucleotide number 
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chr2:25.384.590 and chr2:25.384.569 (UCSC human genome browser hg19)). The grey 
dotted line shows the variation in mean methylation values from the intron (CpG positions -2 
and -1) to the exon at CpG positions +4 to +7. The error bars represent standard deviation 
(SD). (C) Linear regression based on the mean value of CpG position -2 to +5 and BMI in the 
German adult cohort (n=228) and (D) in MSH laser-microdissected neurons from 
postmortem human brain samples (n=41).  
Figure 2: 
Cross-tissue correlations in intra-individual POMC methylation and stability over time. 
(A) POMC DNA methylation at CpG positions -2 to +5 correlates significantly between laser-
microdissected MSH neurons and laser-microdissected blood cells (n=14). (B) Intra-
individual correlation between the POMC DNA methylation (%) at CpG position -2 to +5 of 
postmortem human brain and kidney tissues. (C) Longitudinal stability of DNA methylation in 
the same individuals measured perinatally and in adolescence (n=52).  
 
Figure 3: 
POMC pyrosequencing analysis in family trios with one obese child. 
Peripheral blood DNA samples from 47 trio families, each with one obese child, were 
analyzed by pyrosequencing. (A) Correlation between paternal and offspring DNA 
methylation at CpG positions -2 to +5. (B) Correlation between maternal and offspring DNA 
methylation CpG positions -2 to +5. 
 
Table 1: 
Correlations between maternal biomarker status around conception and offspring DNA 
methylation. 
(A) Environmental impact on peripheral blood DNA methylation in 144 children from The 
Gambia who were conceived during either the dry or rainy season. DNA methylation was 
analyzed against maternal periconceptional methyl-donor biomarker status (Dominguez-
Salas et al., 2014). Season of conception, maternal betaine, SAH and the SAM/SAH ratio 
predict offspring mean methylation across the POMC VMR. CI, confidence interval; coef, 
coefficient; CpG, CpG site within POMC locus; DMG, dimethylglycine; p, p-value; SAM, s-
adenosylmethionine; SAH, s-adenosylhomocysteine; se, standard error; z, z-value (B) 
Summary of SAM, SAM/SAH ratio and betaine dependent DNA methylation at individual 
POMC CpG positions -2 to +7. Associations between SAH, SAM:SAH and methylation show 
no significant differential effect with CpG site.  Methylation associated with betaine varies by 
CpG site (see Supplementary Material).  
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A                                                                                       B 
Predictor CpG Coef. se z P [95% CI]  
SAH
 
-2 -0.29 0.10 -2.99 0.003 -0.47 -0.10 
-1 -0.33 0.11 -2.95 0.004 -0.55 -0.11 
1 -0.41 0.11 -3.58 < 0.001 -0.63 -0.18 
2 -0.32 0.14 -2.30 0.023 -0.60 -0.05 
3 -0.34 0.12 -2.76 0.007 -0.59 -0.10 
4 -0.32 0.12 -2.63 0.009 -0.57 -0.08 
5 -0.59 0.16 -3.58 < 0.001 -0.91 -0.26 
6 -0.40 0.12 -3.34 0.001 -0.64 -0.16 
7 -0.32 0.16 -2.00 0.048 -0.64 0.01 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SAM:SAH
 
-2 0.21 0.10 2.11 0.036 0.01 0.40 
-1 0.23 0.11 2.08 0.039 0.01 0.46 
1 0.33 0.12 2.81 0.006 0.10 0.56 
2 0.24 0.14 1.66 0.099 -0.05 0.52 
3 0.28 0.13 2.23 0.028 0.03 0.53 
4 0.23 0.12 1.83 0.070 -0.02 0.47 
5 0.58 0.17 3.50 0.001 0.25 0.91 
6 0.35 0.12 2.92 0.004 0.11 0.59 
7 0.25 0.16 1.58 0.117 -0.06 0.57 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
betaine
 
-2 0.04 0.09 0.46 0.647 -0.14 0.23 
-1 0.07 0.11 0.64 0.525 -0.14 0.28 
1 0.10 0.11 0.89 0.378 -0.12 0.32 
2 0.34 0.13 2.63 0.010 0.08 0.59 
3 0.32 0.12 2.69 0.008 0.08 0.56 
4 0.35 0.11 3.03 0.003 0.12 0.57 
5 0.28 0.16 1.72 0.088 -0.04 0.60 
6 0.37 0.11 3.23 0.002 0.14 0.60 
7 0.16 0.15 1.09 0.278 -0.13 0.46 
 
 
 
  
covariate coef. se z p [95% CI] 
 Season (dry) -0.152 0.07 -2.14 0.034 -0.291 -0.012 
folate 0.070 0.09 0.79 0.432 -0.106 0.247 
B12 0.017 0.09 0.18 0.854 -0.164 0.197 
B2 -0.108 0.15 -0.73 0.467 -0.402 0.185 
B6 -0.071 0.10 -0.71 0.482 -0.270 0.128 
choline 0.095 0.12 0.78 0.437 -0.146 0.336 
betaine 0.275 0.10 2.80 0.006 0.081 0,470 
methionine 0.211 0.19 1.13 0.262 -0.160 0.583 
cysteine 0.158 0.30 0.53 0.594 -0.429 0.746 
homocysteine -0.187 0.11 -1.67 0.098 -0.410 0.035 
DMG 0.002 0.06 0.03 0.975 -0.125 0.129 
SAM -0.135 0.22 -0.62 0.537 -0.568 0.297 
SAH -0.353 0.10 -3.57 0.001 -0.549 -0.157 
SAM:SAH ratio 0.340 0.10 3.34 0.001 0.138 0.541 
betaine:DMG 
ratio 0.093 0.06 1.59 0.114 -0.022 0.208 
BMI -0.006 0.01 -0.53 0.599 -0.029 0.017 
Table 1 
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